These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 14717005

  • 1. [Why do patients with kidney diseases end up with a heart of stone? Disturbances in calcium-phosphate balance and chronic inflammation important causes].
    Martola L, Elinder CG, Stenvinkel P.
    Lakartidningen; 2003 Dec 11; 100(50):4180-3. PubMed ID: 14717005
    [Abstract] [Full Text] [Related]

  • 2. Effects of calcium on cardiovascular events in patients with kidney disease and in a healthy population.
    West SL, Swan VJ, Jamal SA.
    Clin J Am Soc Nephrol; 2010 Jan 11; 5 Suppl 1():S41-7. PubMed ID: 20089502
    [Abstract] [Full Text] [Related]

  • 3. Vascular calcification in patients with end-stage renal disease.
    Floege J, Ketteler M.
    Nephrol Dial Transplant; 2004 Aug 11; 19 Suppl 5():V59-66. PubMed ID: 15284362
    [Abstract] [Full Text] [Related]

  • 4. Interactions between inflammation, oxidative stress, and endothelial dysfunction in end-stage renal disease.
    Stenvinkel P.
    J Ren Nutr; 2003 Apr 11; 13(2):144-8. PubMed ID: 12671839
    [Abstract] [Full Text] [Related]

  • 5. [Cardiovascular calcification and accelerated atherosclerosis in chronic kidney disease].
    Cozzolino M, Butti A, Chiarelli G, Rocca-Rey L, Santagostino G, Gallieni M, Brancaccio D.
    Ital Heart J Suppl; 2005 Jan 11; 6(1):25-8. PubMed ID: 15776728
    [Abstract] [Full Text] [Related]

  • 6. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients.
    Wang AY, Woo J, Lam CW, Wang M, Chan IH, Gao P, Lui SF, Li PK, Sanderson JE.
    Nephrol Dial Transplant; 2005 Aug 11; 20(8):1676-85. PubMed ID: 15899935
    [Abstract] [Full Text] [Related]

  • 7. [Can cardiovascular calcifications be prevented in chronic kidney disease?].
    Coen G, Manni M, Mantella D, Splendiani G.
    G Ital Nefrol; 2006 Aug 11; 23 Suppl 34():S21-5. PubMed ID: 16633990
    [Abstract] [Full Text] [Related]

  • 8. [Recent advances in the prevention of cardiovascular morbidity and mortality in end-stage renal disease: role of anemia, hyperparathyroidism and calcifications].
    Del Vecchio L, Pozzoni P, Limardo M, Caruso S, Fortunato M, Pontoriero G, Locatelli F.
    G Ital Nefrol; 2007 Aug 11; 24 Suppl 38():25-32. PubMed ID: 17922444
    [Abstract] [Full Text] [Related]

  • 9. Cardiovascular calcification in nondialyzed patients with chronic kidney disease.
    Qunibi WY.
    Semin Dial; 2007 Aug 11; 20(2):134-8. PubMed ID: 17374087
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of morbidity and mortality data related to cardiovascular calcification from calcium-containing phosphate binder use in patients undergoing hemodialysis.
    Mason MA, Shepler BM.
    Pharmacotherapy; 2010 Jul 11; 30(7):741-8. PubMed ID: 20575637
    [Abstract] [Full Text] [Related]

  • 11. Vascular calcification in dialysis patients: pathogenesis and consequences.
    Reslerova M, Moe SM.
    Am J Kidney Dis; 2003 Mar 11; 41(3 Suppl 1):S96-9. PubMed ID: 12612962
    [Abstract] [Full Text] [Related]

  • 12. Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease.
    Yao Q, Pecoits-Filho R, Lindholm B, Stenvinkel P.
    Scand J Urol Nephrol; 2004 Mar 11; 38(5):405-16. PubMed ID: 15764253
    [Abstract] [Full Text] [Related]

  • 13. Disordered mineral metabolism and vascular calcification in nondialyzed chronic kidney disease patients.
    Mehrotra R.
    J Ren Nutr; 2006 Apr 11; 16(2):100-18. PubMed ID: 16567266
    [Abstract] [Full Text] [Related]

  • 14. Cardiovascular calcification in patients with end-stage renal disease.
    Pecovnik-Balon B.
    Ther Apher Dial; 2005 Jun 11; 9(3):208-10. PubMed ID: 15966990
    [Abstract] [Full Text] [Related]

  • 15. [Hyperphosphatemia and cardiovascular risk in patients on dialysis].
    Basić-Jukić N, Kes P.
    Acta Med Croatica; 2004 Jun 11; 58(3):207-13. PubMed ID: 15503684
    [Abstract] [Full Text] [Related]

  • 16. [Chronic inflammation and cardiovascular risk in hemodialysis].
    Pertosa G, Simone S, Soccio M, Marrone D, Grandaliano G.
    G Ital Nefrol; 2003 Jun 11; 20(6):631-40. PubMed ID: 14732917
    [Abstract] [Full Text] [Related]

  • 17. [Prevention of extraskeletal calcifications in uremia].
    Cozzolino M, Galassi A, Bellasi A, Butti A, Zoni U, Gallieni M, Brancaccio D.
    G Ital Nefrol; 2005 Jun 11; 22 Suppl 31():S53-5. PubMed ID: 15786403
    [Abstract] [Full Text] [Related]

  • 18. Importance of hyperphosphataemia in the cardio-renal axis.
    Goodman WG.
    Nephrol Dial Transplant; 2004 Mar 11; 19 Suppl 1():i4-8. PubMed ID: 15126647
    [Abstract] [Full Text] [Related]

  • 19. Different risk factors for vascular calcification in end-stage renal disease between diabetics and nondiabetics: the respective importance of glycemic and phosphate control.
    Ishimura E, Okuno S, Taniwaki H, Kizu A, Tsuchida T, Shioi A, Shoji T, Tabata T, Inaba M, Nishizawa Y.
    Kidney Blood Press Res; 2008 Mar 11; 31(1):10-5. PubMed ID: 18097148
    [Abstract] [Full Text] [Related]

  • 20. Why do dialysis patients develop a heart of stone and bone of china?
    Martola L, Barany P, Stenvinkel P.
    Blood Purif; 2005 Mar 11; 23(3):203-10. PubMed ID: 15809503
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.